Complete Genome Sequence of Capripoxvirus Strain KSGP 0240 from a Commercial Live Attenuated Vaccine

Frank Vandenbussche; Elisabeth Mathijs; Andy Haegeman; Ahmad Al-Majali; Steven Van Borm; Kris De Clercq

doi:10.1128/genomeA.01114-16

Complete Genome Sequence of Capripoxvirus Strain KSGP 0240 from a Commercial Live Attenuated Vaccine

Genome Announc. 2016 Oct 20;4(5):e01114-16. doi: 10.1128/genomeA.01114-16.

Authors

Frank Vandenbussche¹, Elisabeth Mathijs¹, Andy Haegeman², Ahmad Al-Majali^{3

4}, Steven Van Borm⁵, Kris De Clercq²

Affiliations

¹ Molecular Platform, Veterinary and Agrochemical Research Centre, Ukkel, Belgium.
² Viral Diseases, Vesicular and Exotic Diseases, Veterinary and Agrochemical Research Centre, Ukkel, Belgium.
³ Jordan Bio-Industries Centre (JOVAC), Amman, Jordan.
⁴ Faculty of Veterinary Medicine, Jordan University of Science and Technology, Irbid, Jordan.
⁵ Molecular Platform, Veterinary and Agrochemical Research Centre, Ukkel, Belgium Steven.VanBorm@coda-cerva.be.

Abstract

Capripoxviruses cause economically important diseases in domestic ruminants in regions endemic for these viruses. We report here the complete genome sequence of the KSGP 0240 vaccine strain from the live attenuated vaccine Kenyavac (JOVAC).

Grants and funding

The research that yielded these results was funded by the Bill and Melinda Gates Foundation (grant agreement; Investment ID OPP1126866), the European Union FP7 project RAPIDIA-FIELD (grant number FP7-289364), the Belgian Federal Public Service of Health, Food Chain Safety and Environment, through the contract RT 15/3 LUMPY SKIN 1, and the Veterinary and Agrochemical Research Centre (CODA-CERVA), Ukkel, Belgium.